A synthetic nonapeptide comprising cysteinyl, phenylalanyl, phenylalanyl, glutaminyl, asparaginyl, cysteinyl, prolyl, lysyl, and glycinamide residues in sequence, with a disulfide bridge joining the two cysteine residues. Its antidiuretic effects are less than those of vasopressin. It is a non-catecholamine vasoconstrictor used in local anaesthetic injections for dental use, and is an ingredient of preparations that have been used for treatment of pain and inflammation of the mouth.
For use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential.
Taibah University, Medina, Saudi Arabia
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.